A Defined and Flexible Pocket Explains Aryl Substrate Promiscuity of the Cahuitamycin Starter Unit-Activating Enzyme CahJ.
Tripathi, A., Park, S.R., Sikkema, A.P., Cho, H.J., Wu, J., Lee, B., Xi, C., Smith, J.L., Sherman, D.H.(2018) Chembiochem 19: 1595-1600
- PubMed: 29742306 
- DOI: https://doi.org/10.1002/cbic.201800233
- Primary Citation of Related Structures:  
5WM2, 5WM3, 5WM4, 5WM5, 5WM6, 5WM7 - PubMed Abstract: 
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.
Organizational Affiliation: 
Life Sciences Institute, University of Michigan, 210 Washtenaw Avenue, Ann Arbor, MI, 48109-2216, USA.